Here’s how in the early morning session, the stock of Acorda Therapeutics, Inc. (ACOR) peaked
Acorda Therapeutics, Inc. (Nasdaq: ACOR) shares skyrocketed 468.03% to 3.92 in the pre-market session Monday, January 4, 2021, after the Company recently revealed that the previously disclosed 1-for-6 reverse stock split of its outstanding and accepted common stock shares had been completed. At 4:01 p.m., the reverse stock break took place. Eastern Time today, and […]
Barclays raises The Goldman Sachs Group Inc. [GS]’s rating to Overweight and price target to $362
Barclays took its The Goldman Sachs Group Inc. [NYSE:GS] rating to the equivalent of Overweight from Equal Weight, and the price target to $362, in a research note dated January 4, 2021. That figure represents around a 37.27% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Morgan […]
Is that why Ocugen, Inc (OCGN) spiked in the premarket session?
Ocugen, Inc (OCGN)stock surged dramatically 120.77% in the premarket today, despite no news or press releases from the biotechgiant. So what do you need to know? And why is OCGNstock trending higher today? Get the hottest stocks to trade every day before the market opens 100% free. Click here now. The only news affecting OCGN […]
The Hartford Financial Services Group Inc. [HIG] gets an upgrade to an Overweight from JP Morgan
JP Morgan took its The Hartford Financial Services Group Inc. [NYSE:HIG] rating to the equivalent of Overweight from Neutral, and the price target to $55 from $52, in a research note dated January 4, 2021. That figure represents around a 12.27% premium from where the company’s shares closed on Thursday. Some new analysts also started […]
Baird upgrades Henry Schein Inc. [HSIC] to an Outperform rating with a $79 price target
Baird took its Henry Schein Inc. [NASDAQ:HSIC] rating to the equivalent of Outperform from Neutral, and the price target to $79 from $70, in a research note dated January 4, 2021. That figure represents around a 18.16% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Barrington Research’s […]
Here’s an insight into the recent surge in Corporate Universe (OTC PINK: COUV)
Corporate Universe (OTC PINK:COUV)previously closed up more than 53% at $0.3291. The stock went up to $0.3599 at the same session, while its lowest single-day price was $0.2301. Meanwhile, its last 52-week range was noted as 0.0003 to 0.4495. Get the hottest stocks to trade every day before the market opens 100% free. Click here […]
Why Ashford Inc (AINC) stock took an aerial route in the early morning session today?
Ashford Inc (AINC stock) surged 38.20% to $8.14 in the morning session on no news or update; however, the Company announced on November 3, 2020, that the American Stock Exchange (NYSE) had accepted the Company’s compliance plan for continued listing. NYSE American notified the Company on August 26, 2020, that the Company was not in […]
H.C. Wainwright reiterates Protalix BioTherapeutics Inc. [PLX] at Buy and assigns price target at $11
H.C. Wainwright maintained its Protalix BioTherapeutics Inc. [AMEX:PLX] rating to the equivalent of Buy but changed the price target to $11, in a research note dated December 31, 2020. That figure represents around a 212.5% premium from where the company’s shares closed on Wednesday. Other analysts also revised their coverage, with H.C. Wainwright’s analysts reiterating […]
Helius Medical Technologies Inc (HSDT) Reveals Reverse Stock Split Before 2020 Last Bell
Helius Medical Technologies Inc. (HSDT) traded 2.50% higher on Wednesday. At $0.42 per share, the HSDT stock is down around 56.80% year to date. Currently, Helius Medical Technologies Inc. (HSDT) has a market cap of $20.54 million. The average volume for HSDT over the past month (560630 shares per day) is below its average volume […]
Masterlink Securities initiates Tesla Inc. [TSLA] at Buy and assigns price target at $750
Masterlink Securities launched its Tesla Inc. [NASDAQ:TSLA] rating to the equivalent of Buy and assigned the price target of $750, in a research note dated December 31, 2020. That figure represents around a 7.95% premium from where the company’s shares closed on Wednesday. Other analysts also revised their coverage, with Jefferies’s analysts downgrading the shares […]
